All stock lists
Unlock the score
Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
Healthcare · Biotechnology
1.78-0.14 (-7.51%)
Insider Score
/ 100
GRCE Insider Score
Grace Therapeutics, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
GRCE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| SG&A Expense | 1.69 M | 2.59 M | 1.99 M | 1.96 M | 2.13 M |
| R&D Expense | 697.00 K | 420.00 K | 462.00 K | 568.00 K | 955.00 K |
| Operating Expenses | 2.38 M | 3.01 M | 2.45 M | 2.53 M | 3.09 M |
| Operating Income | -2.38 M | -3.01 M | -2.45 M | -2.53 M | -3.09 M |
| Pretax Income | -15.79 M | -2.88 M | -2.31 M | -938.00 K | -3.36 M |
| Tax Provision | 0.00 | -1.70 M | 0.00 | 0.00 | 0.00 |
| Net Income | -15.79 M | -1.18 M | -2.31 M | -938.00 K | -3.36 M |
| EPS (Basic) | -0.91 | — | -0.14 | -0.06 | -0.21 |
| EPS (Diluted) | -0.91 | — | -0.14 | -0.06 | -0.21 |
| Shares Outstanding | 17.27 M | — | 16.93 M | 15.92 M | 15.92 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.